Hasan Mutlu
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Conservation top 2%
- Art Therapy and Mental Health
Papers in
- Oncology 29
- Inflammatory Biomarkers in Disease Prognosis 11
- Cancer Treatment and Pharmacology 7
- Lung Cancer Research Studies 3
-
- Brain Metastases and Treatment 4
- Renal cell carcinoma treatment 3
- Co-authors
- Hasan Şenol Çoşkun (27 shared papers)Deniz Tural (11 shared papers)Yasemin Benderli Cihan (8 shared papers)Hakan Bozcuk (8 shared papers)Abdülsamet Erden (9 shared papers)Mustafa Özdoğan (9 shared papers)Mükremın Uysal (11 shared papers)Ertan Yılmaz (1 shared paper)
In The Last Decade
Hasan Mutlu
65 papers receiving 721 citations
Peers
Comparison fields: 5 of 95
- Oncology 380
- Conservation 41
- Internal Medicine 23
- Cancer Research 76
- Otorhinolaryngology 18
Countries citing papers authored by Hasan Mutlu
This map shows the geographic impact of Hasan Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Mutlu more than expected).
Fields of papers citing papers by Hasan Mutlu
This network shows the impact of papers produced by Hasan Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Mutlu. The network helps show where Hasan Mutlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hasan Mutlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 63 | |
| 2 | 2015 | 59 | |
| 3 | 2016 | 56 | |
| 4 | 2012 | 44 | |
| 5 | 2014 | 41 | |
| 6 | 2014 | 32 | |
| 7 | 2014 | 31 | |
| 8 | 2011 | 30 | |
| 9 | 2015 | 30 | |
| 10 | 2013 | 29 | |
| 11 | 2014 | 25 | |
| 12 | 2014 | 22 | |
| 13 | 2015 | 22 | |
| 14 | 2015 | 17 | |
| 15 | 2016 | 17 | |
| 16 | 2014 | 16 | |
| 17 | 2012 | 14 | |
| 18 | 2015 | 13 | |
| 19 | 2013 | 13 | |
| 20 | 2013 | 10 |
About Hasan Mutlu
Hasan Mutlu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 69 papers that have together received 747 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (11 papers), Cancer Treatment and Pharmacology (7 papers), Brain Metastases and Treatment (4 papers), Renal cell carcinoma treatment (3 papers), Lung Cancer Research Studies (3 papers), Vitamin D Research Studies (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Blood groups and transfusion (3 papers). The work is most often cited by research in Oncology (380 citations), Conservation (41 citations), Internal Medicine (23 citations), Cancer Research (76 citations) and Otorhinolaryngology (18 citations). Hasan Mutlu has collaborated with scholars based in Türkiye, Italy and Germany. Frequent co-authors include Hasan Şenol Çoşkun, Deniz Tural, Yasemin Benderli Cihan, Hakan Bozcuk, Abdülsamet Erden, Mustafa Özdoğan, Mükremın Uysal, Ertan Yılmaz, Ali Akman and Tarık Artiş. Their work appears in journals such as Therapeutics and Clinical Risk Management, Asian Pacific Journal of Cancer Prevention, Journal of Oncology Pharmacy Practice, European Journal of Cancer Prevention and SAE technical papers on CD-ROM/SAE technical paper series.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.